Premenstrual dysphoric disorder is a severe form of premenstrual syndrome that causes significant emotional and physical symptoms during the luteal phase of the menstrual cycle. PMDD symptoms may include depressed mood, anxiety and depression, mood symptoms, irritability, low energy, food cravings, breast tenderness, breast pain, muscle pain, fluid retention, and functional impairment that disrupts usual activities. Symptoms typically improve after the period starts or at the onset of menses.
PMDD is classified as a psychiatric disorder in the Statistical Manual of Mental Disorders by the American Psychiatric Association and is considered part of a broader group of Premenstrual Disorders. Risk factors may include family history, sensitivity to hormonal changes, and underlying mood disorders such as major depression, major depressive disorder, or postpartum depression.
PMDD treatment options focus on evidence-based and individualized care. Treatment of PMDD may include Selective serotonin reuptake inhibitors used continuously or with intermittent dosing, oral contraceptives containing ethinyl estradiol, or hormonal strategies aimed at ovarian suppression such as GnRH agonists when severe PMS or severe symptoms persist. Coordination with an OB/GYN or Women’s Health provider is often essential for comprehensive care.
Michael Feldman, PA-C, brings extensive experience to Psychiatric Mental Health treatment through a rare combination of scientific research and clinical practice. With an academic foundation in molecular and cellular biology, he understands how biological processes influence mental health conditions and psychiatric responses.
After earning his M.Sc. from The Hebrew University of Jerusalem, PA Feldman participated in advanced research at institutions including the Weizmann Institute of Science and Mount Sinai Hospital in New York. He later completed the Physician Assistant program at PACE University – Lenox Hill Hospital in 2017.
Since then, he has worked in both inpatient and outpatient psychiatric practice settings, treating complex psychiatric conditions such as anxiety disorders, psychotic disorders, postpartum depression, autism spectrum disorder, ADHD, and resistant depression. His clinical experience allows him to stay informed about advancements in psychiatric medications, Transcranial Magnetic Stimulation, nasal spray treatments, and psychiatric medication management, ensuring patients receive evidence-based treatment options.
Fluent in English, Russian, and Hebrew, PA Feldman provides compassionate care grounded in cultural sensitivity and personalized mental healthcare.
Begin a journey of self-discovery, support, and expert care—one step at a time. We’re here to guide you with compassion
and clarity.
Book a free consultation online or by phone.
Get matched with a provider suited to your needs.
Start therapy or treatment at your own pace.
One of the most nicest, kindest and considerate doctors I met.
He went over with me thoroughly on the documents and was generous enough to explain me everything that I asked.
I think he is a real doctor of people and not just someone that’s write prescriptions.
I wanted to sincerely thank Dr Feldman for his help during my time in the U.S.
His support, especially when my country was under attack, flights were grounded and medication was hard to access, made a real difference.
He was very kind, professional, and helped me get exactly what I needed in the best and most thoughtful way.
Have questions about our health solutions or need support? Reach out using the form below, and our specialized team will respond promptly to assist you.
(201) 815-4351
440 West Str, Ste 307, Fort Lee Bergen County NJ 07024
A Psychiatrist evaluates and treats a wide range of mental health conditions using medical, diagnostic, and evidence-based approaches. This can include psychiatric evaluations, psychiatric medication management, and ongoing monitoring for conditions such as mood disorders, anxiety disorders, panic disorder, obsessive-compulsive disorder, personality disorders, eating disorders, psychotic disorders, Attention Deficit Hyperactivity Disorder, treatment-resistant depression, postpartum depression, and substance abuse. The goal is improved stability, functioning, and overall quality of life.
PMDD Treatment involves structured psychiatric evaluation and evidence-based medication management designed to stabilize severe mood symptoms linked to the menstrual cycle. Premenstrual Dysphoric Disorder (PMDD) is a clinically recognized mood disorder characterized by intense emotional and behavioral symptoms that occur during the luteal phase and resolve shortly after menstruation begins.
Unlike typical Premenstrual Syndrome (PMS), PMDD causes significant functional impairment. Individuals may experience severe irritability, pronounced mood swings, depressive symptoms, anxiety before menstruation, anger outbursts, emotional sensitivity, fatigue, sleep disturbance, and difficulty concentrating. These symptoms can interfere with work performance, interpersonal relationships, and overall quality of life.
PMDD Treatment begins with comprehensive psychiatric assessment to confirm cyclical symptom timing and rule out underlying mood disorders such as major depressive disorder or bipolar disorder. Symptom tracking across multiple cycles is often used to establish diagnostic clarity.
Selective serotonin reuptake inhibitors (SSRIs) are considered first-line pharmacological treatment for PMDD. These medications target serotonin dysregulation associated with hormonal sensitivity during the luteal phase. SSRIs may be prescribed continuously throughout the month or intermittently during the luteal phase only, depending on symptom pattern.
Follow-up appointments assess irritability reduction, mood stabilization, anxiety improvement, and overall functional recovery. The goal of PMDD Treatment is consistent emotional regulation and reduction of severe cyclical mood disruption.
PMDD differs from PMS primarily in severity and functional impact. While PMS may include mild irritability, fatigue, bloating, or mood swings, PMDD involves severe emotional dysregulation that significantly disrupts daily functioning.
PMDD symptoms include marked irritability, intense mood swings, depressive mood, anxiety, anger, emotional lability, difficulty concentrating, and feelings of hopelessness before menstruation. These symptoms are cyclical and occur specifically during the luteal phase of the menstrual cycle.
PMS Treatment may not always require psychiatric medication, but PMDD Treatment frequently involves pharmacological intervention due to symptom severity. Accurate diagnosis requires consistent symptom timing across cycles and clear functional impairment.
Differentiating PMDD from underlying depressive or anxiety disorders is essential because treatment approaches differ. PMDD responds particularly well to SSRIs, even with intermittent dosing.
PMDD is not caused by abnormal hormone levels but by heightened sensitivity to normal hormonal fluctuations. During the luteal phase, changes in estrogen and progesterone influence serotonin pathways in the brain. Individuals with PMDD appear to have increased sensitivity to these neurochemical shifts.
This serotonin dysregulation can trigger severe irritability, depressive symptoms, anxiety, emotional reactivity, and mood instability before menstruation. The biological mechanism explains why SSRIs are highly effective in PMDD Treatment.
Psychiatric evaluation assesses symptom patterns, emotional volatility, and co-occurring conditions to ensure accurate diagnosis and targeted intervention.
Selective serotonin reuptake inhibitors (SSRIs) are the primary medication used in PMDD Treatment. They stabilize serotonin pathways affected by hormonal fluctuation. SSRIs may be prescribed continuously or only during the luteal phase.
Serotonin-norepinephrine reuptake inhibitors (SNRIs) may be considered when anxiety and depressive symptoms are pronounced. Medication management includes gradual dose titration and side effect monitoring.
Follow-up appointments assess emotional stability, irritability reduction, and functional improvement.
Yes. Premenstrual Dysphoric Disorder can cause depressive symptoms that are intense enough to resemble major depressive disorder, but the key distinction is cyclical timing. Individuals with PMDD often experience pronounced sadness, hopelessness, tearfulness, emotional withdrawal, and loss of interest in usual activities during the luteal phase of the menstrual cycle. These symptoms typically improve within a few days after menstruation begins.
The depressive component of PMDD may include fatigue, sleep disturbance, changes in appetite, difficulty concentrating, and feelings of worthlessness. Because these symptoms overlap with clinical depression, careful psychiatric evaluation is necessary to distinguish cyclical PMDD-related depression from persistent depressive disorders. Misclassification can lead to ineffective treatment planning.
PMDD Treatment involves confirming symptom timing across multiple cycles. When depressive symptoms are strictly linked to hormonal fluctuation, selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment. SSRIs have been shown to reduce both mood instability and depressive symptoms associated with luteal phase hormonal sensitivity. In some cases, serotonin-norepinephrine reuptake inhibitors (SNRIs) may be considered if anxiety and low mood coexist.
Medication management includes dose titration, monitoring for side effects, and evaluating functional improvement in work performance, interpersonal relationships, and overall emotional stability. Follow-up appointments assess reduction in sadness, irritability, and emotional reactivity across cycles.
Because PMDD-related depression can be severe, early psychiatric intervention is important. Effective PMDD Treatment focuses on stabilizing serotonin regulation and reducing the cyclical depressive symptoms that disrupt daily life.
PMDD is diagnosed through a structured psychiatric evaluation that confirms the cyclical nature and severity of symptoms. Unlike many mood disorders, PMDD requires documentation that symptoms occur during the luteal phase of the menstrual cycle and resolve shortly after menstruation begins. This cyclical pattern is central to diagnosis.
Core diagnostic symptoms include severe irritability, marked mood swings, emotional lability, anxiety, depressive mood, anger outbursts, difficulty concentrating, sleep disturbance, and decreased interest in normal activities. Importantly, these symptoms must cause meaningful impairment in occupational functioning, academic performance, social interactions, or intimate relationships.
PMDD Treatment begins with detailed clinical history and often includes prospective symptom tracking across at least two menstrual cycles. This tracking helps confirm that symptoms are hormonally triggered rather than persistent. The evaluation also rules out bipolar disorder, major depressive disorder, generalized anxiety disorder, and other psychiatric conditions that may present with overlapping symptoms.
Neurobiological research suggests that PMDD reflects abnormal sensitivity to normal hormonal fluctuations, particularly involving serotonin dysregulation during the luteal phase. This explains why SSRIs are highly effective even when used intermittently.
Accurate diagnosis ensures targeted PMDD Treatment. Once confirmed, medication management and structured follow-up can significantly reduce emotional volatility and restore consistent functioning throughout the menstrual cycle.
Yes. PMDD can significantly impair work performance, productivity, and interpersonal relationships due to severe mood instability and emotional dysregulation. During the luteal phase, individuals may experience heightened irritability, anger, emotional sensitivity, and difficulty concentrating. These symptoms can lead to workplace conflict, decreased productivity, and strained professional interactions.
In relationships, PMDD-related mood swings and irritability can create misunderstandings, arguments, and emotional distance. Emotional lability may cause individuals to react more intensely to minor stressors, leading to interpersonal tension. Feelings of sadness or anxiety may also contribute to social withdrawal or decreased engagement in previously enjoyable activities.
PMDD Treatment addresses not only symptom reduction but also functional restoration. Psychiatric evaluation assesses the degree of impairment in work and relationships, which is a key diagnostic criterion for PMDD. Medication management, particularly with SSRIs, can reduce irritability, emotional reactivity, and depressive symptoms associated with hormonal fluctuation.
Follow-up appointments monitor improvements in frustration tolerance, emotional regulation, and cognitive clarity across cycles. Many individuals report improved communication, increased productivity, and more stable relationships once PMDD symptoms are effectively managed.
Because PMDD can have cyclical but severe functional consequences, early treatment helps prevent ongoing relational strain and occupational disruption.
If you have ever wondered why your anxiety...Read More
If you have ever started psychiatric medication and...Read More
Anxiety is one of the most common mental...Read More
Finding the right psychiatrist NJ is one of...Read More
Anger is a normal emotion, but when it...Read More
Premenstrual Dysphoric Disorder is a severe form of...Read More
Comprehensive services are designed for each individual. Treatment of Anxiety, Depression, ADHD, Eating Disorders,
Psychosis, schizophrenia, and other psychiatric conditions.
Sign up to our newsletter
